Shattuck Labs Inc.
About Shattuck Labs Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Private Placement T: - FT: Private Placement |
A: 103000000 MR: - FA: Up to approximately $103 million FAN: 103000000 |
D: 2025-08-05 FD: 2025-08-05 |
7 investors |
| 2 |
RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement |
A: 50000000 MR: - FA: approximately $50 million FAN: 50000000 |
D: 2023-12-21 FD: 2023-12-21 |
- |
Growth Metrics
Team & Leadership
Helen Boudreau
Financial Expert and Committee Chair
Tyler Brous
Managing Director and Portfolio Manager
Carrie Brownstein
Former Chief Medical Officer of Zentalis Pharmaceuticals
Neil Gibson
Chief Scientific Officer, Biologics
George Golumbeski
Chairman of the Board and Former Executive Vice President of Business Development for Celgene
Clay Siegall
President, Chief Executive Officer and Chairman of the Board of Immunome, Inc.
Recent News
Shattuck Labs Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- shattucklabs.com
- Industries
- Biotechnology / Healthcare
- Company Size
- ~540 employees (est.)
- Locations
-
Austin, Texas and Durham, North Carolina
Austin, TX and Durham, NC
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro